Cargando…

美法仑联合大剂量地塞米松一线治疗原发性轻链型淀粉样变的疗效分析

OBJECTIVE: To evaluate the response of oral melphalan plus high-dose dexamethasone (MDex) for patients with primary light chain amyloidosis (pAL). METHODS: Clinical data, hematological and organ responses, and survival of 76 patients with pAL who had received MDex from January 2009 to July 2017 were...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342839/
https://www.ncbi.nlm.nih.gov/pubmed/30180464
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.08.006

Ejemplares similares